ArticleClinical and experimental hepatology2018

Ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in HCV genotype 1 infected patients who failed previous protease inhibitor therapy.

Béla Hunyady et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.